AAAAAA

   
Results: 1-23 |
Results: 23
Tob is a negative regulator of activation that is expressed in anergic andquiescent T cells
Authors: Tzachanis, D Freeman, GJ Hirano, N van Puijenbroek, AAFL Delfs, MW Berezovskaya, A Nadler, LM Boussiotis, VA
Citation: D. Tzachanis et al., Tob is a negative regulator of activation that is expressed in anergic andquiescent T cells, NAT IMMUNOL, 2(12), 2001, pp. 1174-1182
The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma
Authors: Friedberg, JW Neuberg, D Monson, J Jallow, H Nadler, LM Freedman, AS
Citation: Jw. Friedberg et al., The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma, BIOL BLOOD, 7(8), 2001, pp. 446-453
Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase
Authors: Vonderheide, RH Anderson, KS Hahn, WC Butler, MO Schultze, JL Nadler, LM
Citation: Rh. Vonderheide et al., Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase, CLIN CANC R, 7(11), 2001, pp. 3343-3348
CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity
Authors: Vonderheide, RH Butler, MO Liu, JF Battle, TE Hirano, N Gribben, JG Frank, DA Schultze, JL Nadler, LM
Citation: Rh. Vonderheide et al., CD40 activation of carcinoma cells increases expression of adhesion and major histocompatibility molecules but fails to induce either CD80/CD86 expression or T cell alloreactivity, INT J ONCOL, 19(4), 2001, pp. 791-798
Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors
Authors: Scardino, A Alves, P Gross, DA Tourdot, S Graff-Dubois, S Angevin, E Firat, H Chouaib, S Lemonier, F Nadler, LM Cardoso, AA Kosmatopoulos, K
Citation: A. Scardino et al., Identification of HER-2/neu immunogenic epitopes presented by renal cell carcinoma and other human epithelial tumors, EUR J IMMUN, 31(11), 2001, pp. 3261-3270
Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals
Authors: Vonderheide, RH Schultze, JL Anderson, KS Maecker, B Butler, MO Xia, ZN Kuroda, MJ von Bergwelt-Baildon, MS Bedor, MM Hoar, KM Schnipper, DR Brooks, MW Letvin, NL Stephans, KF Wucherpfennig, KW Hahn, WC Nadler, LM
Citation: Rh. Vonderheide et al., Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals, CANCER RES, 61(23), 2001, pp. 8366-8370
A pilot study of combined immunotherapy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2
Authors: Schultze, JL Anderson, KC Gilleece, MH Gribben, JG Nadler, LM
Citation: Jl. Schultze et al., A pilot study of combined immunotherapy with autologous adoptive tumour-specific T-cell transfer, vaccination with CD40-activated malignant B cells and interleukin 2, BR J HAEM, 113(2), 2001, pp. 455-460
Interleukin-7 promotes survival and cell cycle progression of T-cell acutelymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p(27kip1)
Authors: Barata, JT Cardoso, AA Nadler, LM Boussiotis, VA
Citation: Jt. Barata et al., Interleukin-7 promotes survival and cell cycle progression of T-cell acutelymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p(27kip1), BLOOD, 98(5), 2001, pp. 1524-1531
Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells
Authors: Ghia, P Transidico, P Veiga, JP Schaniel, C Sallusto, F Matsushima, K Sallan, SE Rolink, AG Mantovani, A Nadler, LM Cardoso, AA
Citation: P. Ghia et al., Chemoattractants MDC and TARC are secreted by malignant B-cell precursors following CD40 ligation and support the migration of leukemia-specific T cells, BLOOD, 98(3), 2001, pp. 533-540
Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: Results of a phase II study
Authors: Longo, DL Duffey, PL Gribben, JG Jaffe, ES Curti, BD Gause, BL Janik, JE Braman, VM Esseltine, D Wilson, WH Kaufman, D Wittes, RE Nadler, LM Urba, WJ
Citation: Dl. Longo et al., Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: Results of a phase II study, CANCER J, 6(3), 2000, pp. 146-150
p27(kip1) functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes
Authors: Boussiotis, VA Freeman, GJ Taylor, PA Berezovskaya, A Grass, I Blazar, BR Nadler, LM
Citation: Va. Boussiotis et al., p27(kip1) functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes, NAT MED, 6(3), 2000, pp. 290-297
Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms
Authors: Datta, MW Shahsafaei, A Nadler, LM Freeman, GJ Dorfman, DM
Citation: Mw. Datta et al., Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms, APPL IMMUNO, 8(3), 2000, pp. 210-215
Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage-colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses
Authors: Stripecke, R Cardoso, AA Pepper, KA Skelton, DG Yu, XJ Mascarenhas, L Weinberg, KI Nadler, LM Kohn, DB
Citation: R. Stripecke et al., Lentiviral vectors for efficient delivery of CD80 and granulocyte-macrophage-colony-stimulating factor in human acute lymphoblastic leukemia and acute myeloid leukemia cells to induce antileukemic immune responses, BLOOD, 96(4), 2000, pp. 1317-1326
Adhesion and costimulatory molecules
Authors: Boussiotis, VA Freeman, GJ Nadler, LM
Citation: Va. Boussiotis et al., Adhesion and costimulatory molecules, CURR MOLEC, 2000, pp. 87-108
A phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphoma
Authors: Grossbard, ML Multani, PS Freedman, AS O'Day, S Gribben, JG Rhuda, C Neuberg, D Nadler, LM
Citation: Ml. Grossbard et al., A phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphoma, CLIN CANC R, 5(9), 1999, pp. 2392-2398
The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes
Authors: Vonderheide, RH Hahn, WC Schultze, JL Nadler, LM
Citation: Rh. Vonderheide et al., The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes, IMMUNITY, 10(6), 1999, pp. 673-679
T cell mediated immunotherapy for B cell lymphoma
Authors: Schultze, JL Nadler, LM
Citation: Jl. Schultze et Lm. Nadler, T cell mediated immunotherapy for B cell lymphoma, J MOL MED-J, 77(3), 1999, pp. 322-331
Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma
Authors: Friedberg, JW Neuberg, D Stone, RM Alyea, E Jallow, H LaCasce, A Mauch, PM Gribben, JG Ritz, J Nadler, LM Soiffer, RJ Freedman, AS
Citation: Jw. Friedberg et al., Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma, J CL ONCOL, 17(10), 1999, pp. 3128-3135
Human macrophage-derived chemokine (MDC) is strongly expressed following activation of both normal and malignant precursor and mature B cells
Authors: Ghia, P Schaniel, C Rolink, AG Nadler, LM Cardoso, AA
Citation: P. Ghia et al., Human macrophage-derived chemokine (MDC) is strongly expressed following activation of both normal and malignant precursor and mature B cells, CURR T MICR, 246, 1999, pp. 103-110
Bone marrow transplantation for low-grade lymphoma and chronic lymphocyticleukemia
Authors: Boussiotis, VA Freedman, AS Nadler, LM
Citation: Va. Boussiotis et al., Bone marrow transplantation for low-grade lymphoma and chronic lymphocyticleukemia, SEM HEMATOL, 36(2), 1999, pp. 209-216
Transplantation of anergic histoincompatible bone marrow allografts
Authors: Guinan, EC Boussiotis, VA Neuberg, D Brennan, LL Hirano, N Nadler, LM Gribben, JG
Citation: Ec. Guinan et al., Transplantation of anergic histoincompatible bone marrow allografts, N ENG J MED, 340(22), 1999, pp. 1704-1714
Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: Role of B cells in the maintenance of T cell responses
Authors: Schultze, JL Michalak, S Lowne, J Wong, A Gilleece, MH Gribben, JG Nadler, LM
Citation: Jl. Schultze et al., Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: Role of B cells in the maintenance of T cell responses, J EXP MED, 189(1), 1999, pp. 1-11
Adoptive T-cell therapy for B-cell acute lymphoblastic leukemia: preclinical studies
Authors: Cardoso, AA Veiga, JP Ghia, P Afonso, HM Haining, WN Sallan, SE Nadler, LM
Citation: Aa. Cardoso et al., Adoptive T-cell therapy for B-cell acute lymphoblastic leukemia: preclinical studies, BLOOD, 94(10), 1999, pp. 3531-3540
Risultati: 1-23 |